Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.
Ciprofloxacin was administered to 12 healthy male volunteers at doses of 300 and 400 mg intravenously (i.v.) and 500 and 750 mg orally in a randomized, double-blind, single-dose, four-period crossover study. On each treatment day, each subject received both oral and i.v. formulations, one of which w...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1992
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188820/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510426/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.5.993 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|